Skip to ContentSkip to Navigation
Practical matters How to find us dr. E.L. van der Veen


89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy

PET/CT Imaging of Zr-89-N-sucDf-Pembrolizumab in Healthy Cynomolgus Monkeys

Development and evaluation of interleukin-2 derived radiotracers for PET imaging of T-cells in mice

Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer F-18-BMS-986192

Radiopharmaceuticals for translational imaging studies in the field of cancer immunotherapy

Zr-89-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs

Clinical-grade N-(4-[18F]fluorobenzoyl)-interleukin-2 for PET imaging of activated T-cells in humans

[Ga-68]Ga-NODAGA-Il2 for imaging activated T-cells

[18F]AlF-RESCA-IL2 for imaging activated T-cells

Read more


BEELDVORMING Opname van radiofarmaca kan respons op immuuntherapie voorspellen